Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension

被引：0
|
作者：
Annette S Droste
David Rohde
Mirko Voelkers
Arthur Filusch
Thomas Bruckner
Mathias M Borst
Hugo A Katus
F Joachim Meyer
机构：
[1] Angiology and Respiratory Medicine,Department of Cardiology
[2] Institute for Medical Biometry and Informatics of the University,undefined
来源：
Respiratory Research | / 10卷
关键词：
Bosentan; Systolic Pulmonary Artery Pressure; Idiopathic Pulmonary Arterial Hypertension; Pulmonary Hemodynamic; Expiratory Airflow;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Endothelin receptor antagonists in pulmonary arterial hypertension
    Dupuis, J.
    Hoeper, M. M.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) : 407 - 415
  • [22] Endothelin receptor antagonists for pulmonary arterial hypertension
    Liu, C.
    Chen, J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03):
  • [23] Endothelin receptor antagonists for pulmonary arterial hypertension
    Liu, Chao
    Chen, Junmin
    Gao, Yanqiu
    Deng, Bao
    Liu, Kunshen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (03):
  • [24] Endothelin receptor antagonists for pulmonary arterial hypertension
    Liu, C.
    Chen, J.
    Gao, Y.
    Deng, B.
    Liu, K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03):
  • [25] Endothelin receptor antagonists in pulmonary arterial hypertension
    Tokgoz, Hacer Ceren
    Can, Mehmet Mustafa
    Kaymaz, Cihangir
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 : 9 - 15
  • [26] Pharmacokinetic and pharmacodynamic evaluation of macitentan, a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension
    Sidharta, Patricia N.
    Kraehenbuehl, Stephan
    Dingemanse, Jasper
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (03) : 437 - 449
  • [27] Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial Hypertension
    Tahara, Nobuhiro
    Dobashi, Hiroaki
    Fukuda, Keiichi
    Funauchi, Masanori
    Hatano, Masaru
    Ikeda, Satoshi
    Joho, Shuji
    Kihara, Yasuki
    Kimura, Takeshi
    Kondo, Takahisa
    Matsushita, Masakazu
    Minamino, Tohru
    Nakanishi, Norifumi
    Ozaki, Yukio
    Saji, Tsutomu
    Sakai, Satoshi
    Tanabe, Nobuhiro
    Watanabe, Hiroshi
    Yamada, Hidehiro
    Yoshioka, Koichiro
    Sasayama, Shigetake
    CIRCULATION JOURNAL, 2016, 80 (06) : 1478 - 1483
  • [28] Novel Dual Endothelin Receptor Antagonist Macitentan Reverses Severe Pulmonary Arterial Hypertension in Rats
    Kunita-Takanezawa, Mutsumi
    Abe, Kohtaro
    Hirooka, Yoshitaka
    Kuwabara, Yukimitsu
    Hirano, Katsuya
    Oka, Masahiko
    Sunagawa, Kenji
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2014, 64 (05) : 473 - 480
  • [29] Clinical features and endothelin receptor antagonist in primary Sjogren's syndrome with pulmonary arterial hypertension
    Chen, C-H
    Chen, H-A
    Yang, K-Y
    Yu, W-C
    Liao, H-T
    Huang, D-F
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (03) : 245 - 247
  • [30] Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience
    Belge, Catharina
    Delcroix, Marion
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
12345